These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16475030)

  • 1. Metastasis predictive signature profiles pre-exist in normal tissues.
    Yang H; Crawford N; Lukes L; Finney R; Lancaster M; Hunter KW
    Clin Exp Metastasis; 2005; 22(7):593-603. PubMed ID: 16475030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications.
    Yang H; Yu LR; Yi M; Lucas DA; Lukes L; Lancaster M; Chan KC; Issaq HJ; Stephens RM; Conrads TP; Veenstra TD; Hunter KW
    J Proteome Res; 2006 Jul; 5(7):1555-67. PubMed ID: 16823962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing expression of NM23 gene in metastatic murine mammary tumors of viral etiology (MMTV).
    Caligo MA; Cipollini G; Cope Di Valromita A; Bistocchi M; Bevilacqua G
    Anticancer Res; 1992; 12(3):969-73. PubMed ID: 1320361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The origins of breast cancer prognostic gene expression profiles.
    Lukes L; Crawford NP; Walker R; Hunter KW
    Cancer Res; 2009 Jan; 69(1):310-8. PubMed ID: 19118016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.
    Hunter KW; Broman KW; Voyer TL; Lukes L; Cozma D; Debies MT; Rouse J; Welch DR
    Cancer Res; 2001 Dec; 61(24):8866-72. PubMed ID: 11751410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
    Urtreger AJ; Werbajh SE; Verrecchia F; Mauviel A; Puricelli LI; Kornblihtt AR; Bal de Kier Joffé ED
    Oncol Rep; 2006 Dec; 16(6):1403-10. PubMed ID: 17089068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular signature of metastasis in primary solid tumors.
    Ramaswamy S; Ross KN; Lander ES; Golub TR
    Nat Genet; 2003 Jan; 33(1):49-54. PubMed ID: 12469122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A six-gene signature predicting breast cancer lung metastasis.
    Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K
    Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection for spontaneous metastasis after calcium phosphate-mediated transfer of DNA.
    Muschel RJ
    Cancer Res; 1990 Sep; 50(17):5581-6. PubMed ID: 2201438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
    Varticovski L; Hollingshead MG; Robles AI; Wu X; Cherry J; Munroe DJ; Lukes L; Anver MR; Carter JP; Borgel SD; Stotler H; Bonomi CA; Nunez NP; Hursting SD; Qiao W; Deng CX; Green JE; Hunter KW; Merlino G; Steeg PS; Wakefield LM; Barrett JC
    Clin Cancer Res; 2007 Apr; 13(7):2168-77. PubMed ID: 17404101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gene expression signatures of melanoma progression.
    Haqq C; Nosrati M; Sudilovsky D; Crothers J; Khodabakhsh D; Pulliam BL; Federman S; Miller JR; Allen RE; Singer MI; Leong SP; Ljung BM; Sagebiel RW; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6092-7. PubMed ID: 15833814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach.
    Tomida S; Yanagisawa K; Koshikawa K; Yatabe Y; Mitsudomi T; Osada H; Takahashi T
    Oncogene; 2007 Jul; 26(31):4600-8. PubMed ID: 17260014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
    Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
    J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles of primary breast tumors maintained in distant metastases.
    Weigelt B; Glas AM; Wessels LF; Witteveen AT; Peterse JL; van't Veer LJ
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15901-5. PubMed ID: 14665696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer.
    Hao JM; Chen JZ; Sui HM; Si-Ma XQ; Li GQ; Liu C; Li JL; Ding YQ; Li JM
    J Pathol; 2010 Mar; 220(4):475-89. PubMed ID: 20077526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.